GoodRx Holdings (GDRX) Change in Receivables (2019 - 2026)

GoodRx Holdings has disclosed Change in Receivables across 8 years of filings, most recently posting -$3.0 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at -$3.0 million, down 121.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $70.8 million (up 361.35% YoY), and the FY2025 annual result was $88.0 million, up 3684.01% from the prior year.
• Change in Receivables came in at -$3.0 million for Q1 2026 at GoodRx Holdings, down from $30.2 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $30.2 million in Q4 2025 to a low of -$31.0 million in Q3 2024.
• The 5-year median for Change in Receivables is $5.2 million (2022), against an average of $6.6 million.
• Across the five-year window, Change in Receivables tumbled 1287.59% in 2024 and soared 1121.62% in 2025, its largest moves.
• GoodRx Holdings' Change in Receivables stood at -$3.7 million in 2022, then jumped by 699.79% to $22.5 million in 2023, then sank by 32.64% to $15.1 million in 2024, then surged by 99.67% to $30.2 million in 2025, then sank by 110.01% to -$3.0 million in 2026.
• The last three Change in Receivables figures came in at -$3.0 million (Q1 2026), $30.2 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.